Menopause Medication May Help to Prevent Invasive Breast Cancer, Study Finds

1. Clinical trial by Northwestern Medicine studied the potential of a menopause drug in preventing invasive breast cancer. 2. The trial found that the drug significantly reduced cell growth in breast tissue. 3. Postmenopausal women with high-risk lesions may benefit the most from the combination of conjugated estrogens and bazedoxifene. 4. The study was conducted between September 2017 and August 2024 with 141 postmenopausal women. 5. Dr. Kulkarni is encouraged by the early results and the drug is already FDA-approved.